BriaCell Therapeutics
(NASDAQ) BCTXZ
BriaCell Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$45.80M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Price
$0.11
Volume
8,243
Open
$0.14
Price
$0.11
Volume
8,243
Open
$0.14
Previous Close
$0.11
Daily Range
$0.11 - $0.14
52-Week Range
$0.06 - $1.51
Dividend
$0.00
Beta (Volatility)
1.92 (High)
Price
$0.11
Volume
8,243
Open
$0.14
Previous Close
$0.11
Daily Range
$0.11 - $0.14
52-Week Range
$0.06 - $1.51
BCTXZ News
BCTXZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BriaCell Therapeutics
BCTXZ Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-97%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
8.24K
Short Interest
0.00%
Avg. Volume
12.23K
Financials (TTM)
Gross Profit
$147.89K
Operating Income
$37.73M
EBITDA
$36.63M
Operating Cash Flow
$28.17M
Capital Expenditure
$3.10
Free Cash Flow
$28.17M
Cash & ST Invst.
$17.87M
Total Debt
$0.00
BriaCell Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$36.98K
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
16
N/A
Net Income
$10.02M
-59.2%
EBITDA
$10.41M
-45.8%
Quarterly Fundamentals
Net Cash
$40.49M
+707.7%
Accounts Receivable
$3.08M
+43.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.01%
N/A
Return on Invested Capital
-97.34%
N/A
Free Cash Flow
$11.05M
-86.6%
Operating Cash Flow
$11.05M
-86.6%